- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
UPDATED Oct 01, 2022
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
8 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PFEPfizer | US$43.76 | -0.7% | 1.9% | US$245.6b | US$55.75 | PE8.3x | E-16.2% | 3.7% | ||
| MRKMerck | US$86.12 | -0.8% | 5.8% | US$218.2b | US$100.00 | PE13.1x | E10.2% | 3.2% | ||
| IRWDIronwood Pharmaceuticals | US$10.36 | 1.8% | -22.3% | US$1.6b | US$13.20 | PE9.2x | E9.2% | n/a | ||
| INVAInnoviva | US$11.61 | -1.6% | -31.8% | US$809.3m | US$19.00 | PE8.1x | S-41.4% | 0% | ||
| SELBSelecta Biosciences | US$1.64 | 9.3% | -60.8% | US$250.4m | US$7.17 | PE7.9x | E-43.1% | n/a | ||
| PRPHProPhase Labs | US$11.28 | 11.0% | 119.9% | US$180.6m | US$15.00 | PE6.8x | E-53.9% | 2.7% | ||
| SESNSesen Bio | US$0.42 | 3.6% | -45.6% | US$84.8m | n/a | PE1.8x | E8.6% | n/a | ||
| RSCFReflect Scientific | US$0.07 | 0% | -70.9% | US$5.9m | n/a | PE7.4x | n/a | n/a |
Page 1 of 1